Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Isopropyl Alcohol for Nausea in a Pediatric Emergency Department
NCT05418244Phase 3Recruiting
- Sponsor
- University at Buffalo
- Start
- Apr 2022
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of Isopropyl alcohol in nausea ((none)) and Vomiting (3 arms), sponsored by University at Buffalo. Primary endpoints: Change in Nausea Score at 30 Minutes, Change in Nausea Score at 10 Minutes and 1 more. Started Apr 2022; status: recruiting.
02
Drugs
Isopropyl alcohol
03
Conditions
nausea ((none))Vomiting
Beyond the preview
Go deeper on NCT05418244.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05418244.